Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
53,401,411
-
Share change
-
-350,042
-
Total reported value
-
$2,208,658,190
-
Price per share
-
$41.36
-
Number of holders
-
176
-
Value change
-
-$15,026,392
-
Number of buys
-
80
-
Number of sells
-
83
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2015
As of 30 Jun 2015,
HAEMONETICS CORP - Common Stock (HAE) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,401,411 shares.
The largest 10 holders included
Neuberger Berman Group LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, BARROW HANLEY MEWHINNEY & STRAUSS LLC, FMR LLC, WESTWOOD HOLDINGS GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, and Black Creek Investment Management Inc..
This page lists
176
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.